Drug Name:Teriparatide
Drug Class:Anabolic agent
Mechanism of Action:
  • Activates osteoblasts
  • Increases bone formation
  • Increases bone mineral density
Use:
  • Treatment of osteoporosis in postmenopausal women and men at high risk of fracture
  • Treatment of glucocorticoid-induced osteoporosis
  • Treatment of osteoporosis in men with primary or hypogonadal osteoporosis
Side Effects:
  • Nausea
  • Dizziness
  • Headache
  • Joint pain
  • Leg cramps
  • Injection site reactions
Contraindications:
  • Hypersensitivity to teriparatide or any component of the formulation
  • Paget's disease of bone
  • Hypercalcemia
  • Metastatic bone disease or bone cancer
  • Pregnancy or breastfeeding
Specialty:
  • Endocrinology
  • Rheumatology
  • Orthopedics